Open Insider Trading Activity for Transcode Therapeutics, Inc. Chief Executive Officer Dudley Robert Michael
31-day price and insider activity (up to 2 years)
Daily candles with triangles for the buy and sale transactions shown below. Scroll left or zoom out to load earlier candles (up to 2 years).
▲ Insider buy
▼ Insider sale
Loading daily price history…
Charting by TradingView Lightweight Charts
| Ticker | Filing Date | Transaction Date | Company | Insider | Title | Transaction | Trade Count | Shares | Avg. Price | Total Value | Position Size Change | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. RNAZ | 2023-10-02 | 2023-09-28 | Transcode Therapeutics, Inc. | Dudley Robert Michael | Chief Executive Officer | Buy | 1 | 98,000 | $0.51 | $49,980.00 | 54.37% | View Filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. RNAZ | 2023-06-22 | 2023-06-21 | Transcode Therapeutics, Inc. | Dudley Robert Michael | Chief Executive Officer | Buy | 2 | 18,607 | $2.61 | $48,647.85 | 12.20% | View Filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. RNAZ | 2023-06-14 | 2023-06-09 | Transcode Therapeutics, Inc. | Dudley Robert Michael | Chief Executive Officer | Buy | 1 | 19,000 | $2.76 | $52,440.00 | 31.07% | View Filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. RNAZ | 2023-06-13 | 2023-06-09 | Transcode Therapeutics, Inc. | Dudley Robert Michael | Chief Executive Officer | Buy | 1 | 19,000 | $2.76 | $52,440.00 | 2.08% | View Filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. RNAZ | 2022-09-16 | 2022-09-14 | Transcode Therapeutics, Inc. | Dudley Robert Michael | Chief Executive Officer | Buy | 1 | 20,000 | $1.15 | $23,000.00 | 2.24% | View Filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. RNAZ | 2022-06-01 | 2022-05-31 | Transcode Therapeutics, Inc. | Dudley Robert Michael | Chief Executive Officer | Buy | 2 | 30,000 | $1.84 | $55,260.00 | 1.72% | View Filing |